Stay updated on Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5. This indicates a small site update with no changes to the study details.
    Difference
    0.0%
    Check dated 2026-06-08T03:49:07.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.5.4, replacing the previous v3.5.3. This indicates a minor update to the page's revision/version metadata rather than changes to visible content.
    Difference
    0.0%
    Check dated 2026-05-17T10:22:52.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page’s footer revision indicator was updated from **v3.5.2** to **v3.5.3**.
    Difference
    0.0%
    Check dated 2026-04-25T18:47:34.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-18T13:37:50.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    - Revision tag updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T01:20:08.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Revision: v3.4.3 updated from the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-06T17:44:14.000Z thumbnail image

Stay in the know with updates to Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page.